Hyperion Pricing On Ravicti Will Test Premium For Convenience In Orphan Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Ravicti’s price tag is $250,000 to $290,000 per year while the upper WAC price for Valeant’s competing product Buphenyl is roughly $240,000 at the maximum dose; Hyperion has option to acquire Buphenyl.